ESMO 2024 - Overall Survival Data from the KEYNOTE-522 Trial with Dr. Peter Schmid Regarder maintenant
ESMO 2024: REVUE quotidienne du jour 1 avec Dr Asselah, Dr Rami Younan et Dre Kim Ma Regarder maintenant
ESMO 2024 - Global Speaker Series - Dr. Nancy Lin on ESMO LBA18: Trastuzumab deruxtecan (T-DXd) in patients with HER2+ advanced/mbc & DESTINYBreast-12 primary results Regarder maintenant
ESMO 2024 - Global Speaker Series - Dr. Alnouri Highlights What to Expect at ESMO 2024: Advances in Breast Cancer Regarder maintenant
ESMO 2024 - Global Speaker Series - De-escalation Strategies in HER2+ Early-Stage Breast Cancer Regarder maintenant
